Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Oncogene ; 36(42): 5914, 2017 10 19.
Article in English | MEDLINE | ID: mdl-28846116

ABSTRACT

This corrects the article DOI: 10.1038/onc.2017.93.

2.
Oncogene ; 36(33): 4778-4789, 2017 08 17.
Article in English | MEDLINE | ID: mdl-28414306

ABSTRACT

KRAS is one of the most frequently mutated oncogenes in human non-small cell lung cancers (NSCLCs). RAS proteins trigger multiple effector signalling pathways including the highly conserved RAF-MAPK pathway. CRAF, a direct RAS effector protein, is required for KRAS-mediated tumourigenesis. Thus, the molecular mechanisms driving the activation of CRAF are intensively studied. Prohibitin 1 (PHB1) is an evolutionarily conserved adaptor protein and interaction of CRAF with PHB1 at the plasma membrane is essential for CRAF activation. Here, we demonstrate that PHB1 is highly expressed in NSCLC patients and correlates with poor survival. Targeting of PHB1 with two chemical ligands (rocaglamide and fluorizoline) inhibits epidermal growth factor (EGF)/RAS-induced CRAF activation. Consistently, treatment with rocaglamide inhibited proliferation, migration and anchorage-independent growth of KRAS-mutated lung carcinoma cell lines. Surprisingly, rocaglamide treatment inhibited Ras-GTP loading in KRAS-mutated cells as well as in EGF-stimulated cells. Rocaglamide treatment further prevented the oncogenic growth of KRAS-driven lung cancer allografts and xenografts in mouse models. Our results suggest rocaglamide as a RAS inhibitor and that targeting plasma membrane-associated PHB1 with chemical ligands would be a viable therapeutic strategy to combat KRAS-mediated NSCLCs.


Subject(s)
Benzofurans/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Molecular Targeted Therapy , Proto-Oncogene Proteins p21(ras)/metabolism , Repressor Proteins/antagonists & inhibitors , Animals , Benzofurans/administration & dosage , Benzofurans/pharmacology , Cell Line, Tumor , Cell Proliferation , EGF Family of Proteins/metabolism , Gene Expression Regulation, Neoplastic , Humans , Ligands , Mice , Mice, Knockout , Prohibitins , Proto-Oncogene Proteins p21(ras)/genetics , Signal Transduction , TNF Receptor-Associated Factor 3/metabolism , Xenograft Model Antitumor Assays , raf Kinases/metabolism , ras Proteins/antagonists & inhibitors , ras Proteins/metabolism
3.
Cell Death Dis ; 5: e1321, 2014 Jul 10.
Article in English | MEDLINE | ID: mdl-25010987

ABSTRACT

Caspase-2 represents the most conserved member of the caspase family, which exhibits features of both initiator and effector caspases. Using ribonucleoprotein (RNP)-immunoprecipitation assay, we identified the proapoptotic caspase-2L encoding mRNA as a novel target of the ubiquitous RNA-binding protein HuR in DLD-1 colon carcinoma cells. Unexpectedly, crosslinking-RNP and RNA probe pull-down experiments revealed that HuR binds exclusively to the caspase-2-5' untranslated region (UTR) despite that the 3' UTR of the mRNA bears several adenylate- and uridylate-rich elements representing the prototypical HuR binding sites. By using RNAi-mediated loss-of-function approach, we observed that HuR regulates the mRNA and in turn the protein levels of caspase-2 in a negative manner. Silencing of HuR did not affect the stability of caspase-2 mRNA but resulted in an increased redistribution of caspase-2 transcripts from RNP particles to translational active polysomes implicating that HuR exerts a direct repressive effect on caspase-2 translation. Consistently, in vitro translation of a luciferase reporter gene under the control of an upstream caspase-2-5'UTR was strongly impaired after the addition of recombinant HuR, whereas translation of caspase-2 coding region without the 5'UTR is not affected by HuR confirming the functional role of the caspase-2-5'UTR. Functionally, an elevation in caspase-2 level by HuR knockdown correlated with an increased sensitivity of cells to apoptosis induced by staurosporine- and pore-forming toxins as implicated by their significant accumulation in the sub G1 phase and an increase in caspase-2, -3 and poly ADP-ribose polymerase cleavage, respectively. Importantly, HuR knockdown cells remained insensitive toward STS-induced apoptosis if cells were additionally transfected with caspase-2-specific siRNAs. Collectively, our findings support the hypothesis that HuR by acting as an endogenous inhibitor of caspase-2-driven apoptosis may essentially contribute to the antiapoptotic program of adenocarcinoma cells by HuR.


Subject(s)
Adenocarcinoma/genetics , Apoptosis , Caspase 2/genetics , Colonic Neoplasms/genetics , Cysteine Endopeptidases/genetics , ELAV Proteins/metabolism , 3' Untranslated Regions , 5' Untranslated Regions , Adenocarcinoma/enzymology , Adenocarcinoma/metabolism , Adenocarcinoma/physiopathology , Caspase 2/metabolism , Cell Line, Tumor , Colonic Neoplasms/enzymology , Colonic Neoplasms/metabolism , Colonic Neoplasms/physiopathology , Cysteine Endopeptidases/metabolism , ELAV Proteins/genetics , Humans , Protein Binding , Protein Biosynthesis , Transcription, Genetic , Up-Regulation
4.
Cell Death Dis ; 4: e784, 2013 Sep 05.
Article in English | MEDLINE | ID: mdl-24008728

ABSTRACT

Inhibitors of Apoptosis Proteins (IAPs) are a class of highly conserved proteins predominantly known for the regulation of caspases and immune signaling. However, recent evidence suggests a crucial role for these molecules in the regulation of tumor cell shape and migration by controlling MAPK, NF-κB and Rho GTPases. IAPs directly control Rho GTPases, thus regulating cell shape and migration. For instance, XIAP and cIAP1 function as the direct E3 ubiquitin ligases of Rac1 and target it for proteasomal degradation. IAPs are differentially expressed in tumor cells and have been targeted by several cancer therapeutic drugs that are currently in clinical trials. Here, we summarize the current knowledge on the role of IAPs in the regulation of cell migration and discuss the possible implications of these observations in regulating tumor cell metastases.


Subject(s)
Cell Movement , Inhibitor of Apoptosis Proteins/metabolism , Animals , Carcinogenesis/pathology , Disease Progression , Humans , Models, Biological , Signal Transduction
5.
Cell Death Dis ; 4: e564, 2013 Mar 28.
Article in English | MEDLINE | ID: mdl-23538445

ABSTRACT

As inhibitor of apoptosis (IAP) proteins can regulate additional signaling pathways beyond apoptosis, we investigated the effect of the second mitochondrial activator of caspases (Smac) mimetic BV6, which antagonizes IAP proteins, on non-apoptotic functions in glioblastoma (GBM). Here, we identify non-canonical nuclear factor-κB (NF-κB) signaling and a tumor necrosis factor-α (TNFα)/TNF receptor 1 (TNFR1) autocrine/paracrine loop as critical mediators of BV6-stimulated migration and invasion of GBM cells. In addition to GBM cell lines, BV6 triggers cell elongation, migration and invasion in primary, patient-derived GBM cells at non-toxic concentrations, which do not affect cell viability or proliferation, and also increases infiltrative tumor growth in vivo underscoring the relevance of these findings. Molecular studies reveal that BV6 causes rapid degradation of cellular IAP proteins, accumulation of NIK, processing of p100 to p52, translocation of p52 into the nucleus, increased NF-κB DNA binding and enhanced NF-κB transcriptional activity. Electrophoretic mobility shift assay supershift shows that the NF-κB DNA-binding subunits consist of p50, p52 and RelB further confirming the activation of the non-canonical NF-κB pathway. BV6-stimulated NF-κB activation leads to elevated mRNA levels of TNFα and additional NF-κB target genes involved in migration (i.e., interleukin 8, monocyte chemoattractant protein 1, CXC chemokine receptor 4) and invasion (i.e., matrix metalloproteinase-9). Importantly, inhibition of NF-κB by overexpression of dominant-negative IκBα superrepressor prevents the BV6-stimulated cell elongation, migration and invasion. Similarly, specific inhibition of non-canonical NF-κB signaling by RNA interference-mediated silencing of NIK suppresses the BV6-induced cell elongation, migration and invasion as well as upregulation of NF-κB target genes. Intriguingly, pharmacological or genetic inhibition of the BV6-stimulated TNFα autocrine/paracrine loop by the TNFα-blocking antibody Enbrel or by knockdown of TNFR1 abrogates BV6-induced cell elongation, migration and invasion. By demonstrating that the Smac mimetic BV6 at non-toxic concentrations promotes migration and invasion of GBM cells via non-canonical NF-κB signaling, our findings have important implications for the use of Smac mimetics as cancer therapeutics.


Subject(s)
Brain Neoplasms/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Glioblastoma/metabolism , Intracellular Signaling Peptides and Proteins/chemistry , Mitochondrial Proteins/chemistry , NF-kappa B/genetics , Peptidomimetics/pharmacology , Protein Subunits/genetics , Apoptosis Regulatory Proteins , Brain Neoplasms/pathology , Cell Line, Tumor , Cell Movement/drug effects , Etanercept , Glioblastoma/pathology , Humans , Immunoglobulin G/pharmacology , Inhibitor of Apoptosis Proteins/genetics , Inhibitor of Apoptosis Proteins/metabolism , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/prevention & control , Protein Subunits/antagonists & inhibitors , Protein Subunits/metabolism , RNA, Small Interfering/genetics , Receptors, Tumor Necrosis Factor , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor, Type I/metabolism , Signal Transduction/drug effects , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
6.
Toxicol Mech Methods ; 23(2): 77-85, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22901014

ABSTRACT

The present investigation explores the anticlastogenic effect of diosgenin on 7,12-dimethylbenz(a)anthracene (DMBA) treated clastogenesis. The frequency of bone marrow micronucleated polychromatic erythrocytes (MnPCEs), chromosomal aberrations (CA), deoxyribonucleic acid (DNA) damage as cytogenetic markers and the levels of lipid peroxidation by-products, activities of enzymatic antioxidant and the status of detoxification agents were performed to assess the anticlastogenic effects of diosgenin on DMBA treated hamsters. Intraperitoneal injection of DMBA (30 mg/kg bw) leads to clastogenesis in hamster. Elevated MnPCEs frequencies, CA, DNA damage, enhanced lipid peroxidation by products, declined antioxidant activities and detoxification cascade were observed in DMBA treated hamsters. Oral pretreatment with diosgenin (80 mg/kg bw) daily for a period of five days significantly reduced the frequency of MnPCEs, CA, DNA damage and normalized the levels of lipid peroxidation by products with increased activities of antioxidants and detoxification agents in DMBA alone treated hamsters. Outcome of the present study revealed that diosgenin has potent anticlastogenic effects on DMBA treated hamsters.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Antimutagenic Agents/pharmacology , Bone Marrow Cells/drug effects , Diosgenin/pharmacology , Mutagens/toxicity , Animals , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Chromosome Aberrations/chemically induced , Chromosome Aberrations/drug effects , Cricetinae , DNA Damage/drug effects , Drug Antagonism , Lipid Peroxidation/drug effects , Male , Mesocricetus , Micronuclei, Chromosome-Defective/chemically induced , Micronuclei, Chromosome-Defective/drug effects , Micronucleus Tests
7.
BMB Rep ; 43(10): 664-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21034528

ABSTRACT

The present study aimed to investigate the membrane stabilizing effect of Thymoquinone (TQ) on cell surface glycoconjugates and cytokeratin expression against DMBA induced hamster buccal pouch carcinogenesis. 0.5% DMBA painting (three times per week) in hamster buccal pouches for 14 weeks resulted in the formation of well developed oral squamous cell carcinoma. We observed 100% tumor formation with marked abnormalities of glycoconjugates status in tumor bearing hamsters as compared to control animals. Oral administration of TQ at a dose of 30 mg/kg body weight, to DMBA painted hamsters on alternate days for 14 weeks, reduced the tumor formation as well as protected the levels of cell surface glycoconjugates in DMBA painted hamsters. The present study thus suggests that TQ has potent chemopreventive efficacy as well as protected the abnormalities on cell surface glycoconjugates during DMBA induced hamster buccal pouch carcinogenesis.


Subject(s)
Benzoquinones/therapeutic use , Carcinoma, Squamous Cell/prevention & control , Keratins/metabolism , Membrane Glycoproteins/metabolism , Mouth Neoplasms/prevention & control , 9,10-Dimethyl-1,2-benzanthracene , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Benzoquinones/pharmacology , Carcinogens , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/metabolism , Chemoprevention/methods , Cricetinae , Drug Evaluation, Preclinical , Glycoconjugates/metabolism , Male , Mesocricetus , Mouth Neoplasms/chemically induced , Mouth Neoplasms/metabolism , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/prevention & control
8.
Phys Chem Chem Phys ; 12(17): 4390-9, 2010 May 07.
Article in English | MEDLINE | ID: mdl-20407711

ABSTRACT

Self-assembled monolayers (SAMs) on gold substrates were prepared from benzylmercaptan (BM) and para-cyanobenzylmercaptan (pCBM), and the resulting surfaces were investigated using conventional infrared reflection-absorption spectroscopy (IRRAS) as well as polarization modulation infrared reflection-absorption spectroscopy (PM-IRRAS). IRRAS data are analyzed by comparison with transmission IR spectra and theoretical (DFT) simulations. The spectroscopic results indicate the presence of well-ordered monolayers of BM and pCBM with an orientation perpendicular to the surface. IRRAS and PM-IRRAS data are compared to each other and the respective merits of both methods are discussed.

9.
Cell Death Dis ; 1: e5, 2010.
Article in English | MEDLINE | ID: mdl-21364624

ABSTRACT

The transcription factor p63 is expressed as at least six different isoforms, of which two have been assigned critical biological roles within ectodermal development and skin stem cell biology on the one hand and supervision of the genetic stability of oocytes on the other hand. These two isoforms contain a C-terminal inhibitory domain that negatively regulates their transcriptional activity. This inhibitory domain contains two individual components: one that uses an internal binding mechanism to interact with and mask the transactivation domain and one that is based on sumoylation. We have carried out an extensive alanine scanning study to identify critical regions within the inhibitory domain. These experiments show that a stretch of ∼13 amino acids is crucial for the binding function. Further, investigation of transcriptional activity and the intracellular level of mutants that cannot be sumoylated suggests that sumoylation reduces the concentration of p63. We therefore propose that the inhibitory function of the C-terminal domain is in part due to direct inhibition of the transcriptional activity of the protein and in part due to indirect inhibition by controlling the concentration of p63.


Subject(s)
Trans-Activators/metabolism , Tumor Suppressor Proteins/metabolism , Amino Acid Sequence , Cell Line, Tumor , Humans , Molecular Sequence Data , Mutation , Protein Binding , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary , Sumoylation , Trans-Activators/chemistry , Trans-Activators/genetics , Transcription Factors , Transcription, Genetic , Tumor Suppressor Proteins/chemistry , Tumor Suppressor Proteins/genetics
10.
Article in English | AIM (Africa) | ID: biblio-1256191

ABSTRACT

The antigenotoxic effect of ferulic acid was carried out by evaluating the cytogenetic markers; the micronuclei frequency and chromosomal aberrations; in the bone marrow of hamsters in 7;12dimethylbenz(a)anthracene (DMBA) induced genotoxicity. Genotoxicity was induced in experimental hamsters by single intraperitoneal injection of DMBA (30mg kg-1 b.w). Pretreatment of ferulic acid orally at a dose of 40mg kg-1 b.w for five days significantly reduced the frequency of micronucleated polychromatic erythrocytes (MnPCEs) and the percentage of chromosomal aberrations in hamster's bone marrow. Our results thus suggest that ferulic acid has potent antigenotoxic effect in DMBA induced genotoxicity in golden Syrian hamsters


Subject(s)
Antioxidants , Chromosome Aberrations , Lipid Peroxidation
11.
Cell Death Differ ; 11(3): 290-300, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14657961

ABSTRACT

c-Abl protein tyrosine kinase plays an important role in cell cycle control and apoptosis. Furthermore, induction of apoptosis correlates with the activation of c-Abl. Here, we demonstrate the cleavage of c-Abl by caspases during apoptosis. Caspases separate c-Abl into functional domains including a Src-kinase, a fragment containing nuclear import sequences, a fragment with an actin-binding domain and nuclear export sequence. Caspase cleavage increases the kinase activity of c-Abl as demonstrated by in vitro kinase assays as well as by auto- and substrate phosphorylation. Cells in which c-Abl expression was knocked down by RNA interference resisted cisplatin- but not TNFalpha-induced apoptosis. A similar selective resistance against cisplatin-induced apoptosis was observed when cleavage resistant c-Abl was overexpressed in treated cells. Our data suggest the selective requirement of c-Abl cleavage by caspases for stress-induced, but not for TNFalpha-induced apoptosis.


Subject(s)
Apoptosis , Caspases/metabolism , Proto-Oncogene Proteins c-abl/metabolism , Stress, Physiological , Amino Acid Motifs , Amino Acid Sequence , Animals , Antibodies, Monoclonal/metabolism , Blotting, Western , Electrophoresis, Gel, Two-Dimensional , Electrophoresis, Polyacrylamide Gel , Enzyme Activation , Fluorescent Antibody Technique, Direct , HeLa Cells , Humans , Jurkat Cells , Mice , Microscopy, Confocal , Molecular Sequence Data , NIH 3T3 Cells , Polymerase Chain Reaction , Precipitin Tests , Protein Kinases/analysis , Protein Structure, Tertiary , Proto-Oncogene Proteins c-abl/chemistry , Proto-Oncogene Proteins c-abl/genetics , RNA Interference , Sequence Homology, Amino Acid , U937 Cells
12.
Infect Immun ; 69(12): 7880-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11705971

ABSTRACT

The obligate intracellular pathogen Chlamydophila pneumoniae (Chlamydia pneumoniae) initiates infections in humans via the mucosal epithelia of the respiratory tract. Here, we report that epithelial cells infected with C. pneumoniae are resistant to apoptosis induced by treatment with drugs or by death receptor ligation. The induction of protection from apoptosis depended on the infection conditions since only cells containing large inclusions were protected. The underlying mechanism of infection-induced apoptosis resistance probably involves mitochondria, the major integrators of apoptotic signaling. In the infected cells, mitochondria did not respond to apoptotic stimuli by the release of apoptogenic factors required for the activation of caspases. Consequently, active caspase-3 was absent in infected cells. Our data suggest a direct modulation of apoptotic pathways in epithelial cells by C. pneumoniae.


Subject(s)
Apoptosis , Chlamydophila pneumoniae/growth & development , Epithelial Cells/microbiology , Apoptosis/drug effects , Caspase 3 , Caspases/metabolism , Cytochrome c Group/metabolism , Enzyme Activation , Humans , Mitochondria/drug effects , Staurosporine/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...